Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review.

@article{Kroon2014IsolatedLI,
  title={Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review.},
  author={Hidde M. Kroon and Anna M. Huismans and Peter C. A. Kam and John F Thompson},
  journal={Journal of surgical oncology},
  year={2014},
  volume={109 4},
  pages={348-51}
}
Isolated limb infusion (ILI) was developed as a simplified and minimally invasive alternative to isolated limb perfusion (ILP) to treat unresectable limb melanoma. A number of centers around the world have reported their results using this procedure. In this study a systematic review of reported ILI experiences was undertaken. A literature search was conducted according to the guidelines for systematic reviews in order to select eligible papers reporting limb toxicity and response rates… CONTINUE READING
9 Citations
38 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Correcting melphalan dose for ideal body weight in isolated limb infusion, does it influence toxicity or response

  • AM Huismans, HM Kroon, LE Haydu
  • Ann Surg Oncol
  • 2012

Similar Papers

Loading similar papers…